Association of a Blood-Based Aging Biomarker Index With Death and Chronic Disease: Cardiovascular Health Study
- 19 July 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 79 (2)
Abstract
Background: A goal of gerontology is to discover phenotypes that reflect biological aging distinct from disease pathogenesis. Biomarkers that are strongly associated with mortality could be used to define such a phenotype. However, the relation of such an index with multiple chronic conditions warrants further exploration. Methods: A biomarker index (BI) was constructed in the Cardiovascular Health Study (N = 3 197), with a mean age of 74 years. The BI incorporated circulating levels of new biomarkers, including insulin-like growth factor-1, interleukin-6, amino-terminal pro-B-type natriuretic peptide, cystatin-C, C-reactive protein, tumor necrosis factor-alpha soluble receptor 1, fasting insulin, and fasting glucose, and was built based on their relationships with mortality. Cox proportional hazards models predicting a composite of death and chronic disease involving cardiovascular disease, dementia, and cancer were calculated with 6 years of follow-up. Results: The hazard ratio (HR, 95% CI) for the composite outcome of death or chronic disease per category of BI was 1.65 (1.52, 1.80) and 1.75 (1.58, 1.94) in women and men, respectively. The HR (95% CI) per 5 years of age was 1.57 (1.48, 1.67) and 1.55 (1.44, 1.67) in women and men, respectively. Moreover, BI could attenuate the effect of age on the composite outcome by 16.7% and 22.0% in women and men, respectively. Conclusions: Biomarker index was significantly and independently associated with a composite outcome of death and chronic disease, and attenuated the effect of age. The BI that is composed of plasma biomarkers may be a practical intermediate phenotype for interventions aiming to modify the course of aging.Keywords
Funding Information
- National Heart, Lung, and Blood Institute
- National Institute of Neurological Disorders and Stroke (R01AG023629, R01AG-15928, R01AG-20098, R01AG-027058, R01AG-21332)
- National Institute on Aging
- Glenn Foundation for Medical Research (1R01AG031890)
This publication has 63 references indexed in Scilit:
- C-Reactive Protein and B-Type Natriuretic Peptide Yield Either a Non-Significant or a Modest Incremental Value to Traditional Risk Factors in Predicting Long-Term Overall Mortality in Older AdultsPLOS ONE, 2013
- Defining and Measuring Chronic Conditions: Imperatives for Research, Policy, Program, and PracticePreventing Chronic Disease, 2013
- Aging with multimorbidity: A systematic review of the literatureAgeing Research Reviews, 2011
- Inflammatory markers in population studies of agingAgeing Research Reviews, 2011
- Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammationScandinavian Journal of Clinical and Laboratory Investigation, 2011
- Long‐Term Function in an Older Cohort—The Cardiovascular Health Study All Stars StudyJournal of the American Geriatrics Society, 2009
- Mortality Rate in Veterans with Multiple Chronic ConditionsJournal of General Internal Medicine, 2007
- Relationship Between Low Levels of Anabolic Hormones and 6-Year Mortality in Older MenThe Aging in the Chianti Area (InCHIANTI) StudyArchives of internal medicine (1960), 2007
- Cardiovascular Mortality Risk in Chronic Kidney DiseaseJAMA, 2005
- The Plasticity of Aging: Insights from Long-Lived MutantsCell, 2005